Hiromi Katae

588 total citations
33 papers, 451 citations indexed

About

Hiromi Katae is a scholar working on Molecular Biology, Pharmacology and Infectious Diseases. According to data from OpenAlex, Hiromi Katae has authored 33 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Pharmacology and 9 papers in Infectious Diseases. Recurrent topics in Hiromi Katae's work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Virus-based gene therapy research (6 papers) and Parasitic Diseases Research and Treatment (5 papers). Hiromi Katae is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (10 papers), Virus-based gene therapy research (6 papers) and Parasitic Diseases Research and Treatment (5 papers). Hiromi Katae collaborates with scholars based in Japan, United States and France. Hiromi Katae's co-authors include Katsuhisa Nakata, Kazuyo Yuri, Shinichi Nakamura, Atsuhiko Hasegawa, Akira Minami, Satoru Inoue, M Shimizu, Masanao Shimizu, Shingo Yamamoto and Jun‐ichi Yamagishi and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, International Journal of Cancer and Veterinary Microbiology.

In The Last Decade

Hiromi Katae

33 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiromi Katae Japan 13 142 122 118 108 84 33 451
J.P. Crane United States 9 143 1.0× 78 0.6× 73 0.6× 110 1.0× 52 0.6× 13 463
JoAnn Dzink-Fox United States 12 117 0.8× 191 1.6× 70 0.6× 259 2.4× 85 1.0× 22 569
Yoshimi Wakai Japan 11 195 1.4× 122 1.0× 220 1.9× 148 1.4× 18 0.2× 16 546
M. Michéa-Hamzehpour Switzerland 10 216 1.5× 214 1.8× 74 0.6× 335 3.1× 50 0.6× 18 554
W. TOSCH Switzerland 10 165 1.2× 274 2.2× 117 1.0× 237 2.2× 57 0.7× 17 669
María Fernández‐Reyes Spain 14 81 0.6× 257 2.1× 31 0.3× 275 2.5× 112 1.3× 16 614
J V Desiderio United States 10 81 0.6× 124 1.0× 106 0.9× 46 0.4× 15 0.2× 12 417
N. Harnett Canada 10 32 0.2× 71 0.6× 71 0.6× 72 0.7× 57 0.7× 23 328
S J Ryan Arends United States 15 163 1.1× 246 2.0× 88 0.7× 316 2.9× 99 1.2× 50 706
Kazunori Maebashi Japan 16 142 1.0× 201 1.6× 256 2.2× 292 2.7× 55 0.7× 42 726

Countries citing papers authored by Hiromi Katae

Since Specialization
Citations

This map shows the geographic impact of Hiromi Katae's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiromi Katae with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiromi Katae more than expected).

Fields of papers citing papers by Hiromi Katae

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiromi Katae. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiromi Katae. The network helps show where Hiromi Katae may publish in the future.

Co-authorship network of co-authors of Hiromi Katae

This figure shows the co-authorship network connecting the top 25 collaborators of Hiromi Katae. A scholar is included among the top collaborators of Hiromi Katae based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiromi Katae. Hiromi Katae is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hisasue, Masaharu, Kazuo Nishigaki, Hiromi Katae, et al.. (2008). Myelodysplastic syndromes and acute myeloid leukemia in cats infected with feline leukemia virus clone33 containing a unique long terminal repeat. International Journal of Cancer. 124(5). 1133–1141. 23 indexed citations
2.
Nakata, Katsuhisa, et al.. (2000). CombinedIn VitroEffects of Orbifloxacin and Fosfomycin on S. Dublin and S. Typhimurium Isolated from Calves. Journal of the Japan Veterinary Medical Association. 53(1). 1–6. 2 indexed citations
3.
Hisasue, Masaharu, Kazuo Nishigaki, Hiromi Katae, et al.. (2000). Clonality Analysis of Various Hematopoietic Disorders in Cats Naturally Infected with Feline Leukemia Virus.. Journal of Veterinary Medical Science. 62(10). 1059–1065. 17 indexed citations
4.
Matsumoto, Shuji, et al.. (1998). Absorption, Distribution and Excretion of Orbifloxacin in Swines and Calves. Journal of the Japan Veterinary Medical Association. 51(1). 13–18. 10 indexed citations
5.
Yuri, Kazuyo, Katsuhisa Nakata, Hiromi Katae, Shingo Yamamoto, & Atsuhiko Hasegawa. (1998). Distribution of Uropathogenic Virulence Factors among <i>Escherichia coli</i> Strains Isolated from Dogs and Cats. Journal of Veterinary Medical Science. 60(3). 287–290. 49 indexed citations
6.
Matsumoto, Shuji, et al.. (1997). Absorption, Distribution and Excretion of Orbifloxacin in Dogs and Cats. Journal of the Japan Veterinary Medical Association. 50(8). 470–474. 10 indexed citations
7.
Yuri, Kazuyo, et al.. (1997). Fungi and bacteria isolated from skin lesions of dogs and their drug sensitivities.. 3(3). 29–35. 1 indexed citations
8.
Yoshida, Motonobu, Kazuhide Nakagaki, Sadao NOGAMI, et al.. (1997). Immunologic Protection against Canine Heartworm Infection.. Journal of Veterinary Medical Science. 59(12). 1115–1121. 12 indexed citations
9.
Tajima, Tomoko, et al.. (1997). Grouping of Feline Calicivirus Field Isolates Using Monoclonal Antibodies.. 1(2). 57–63. 5 indexed citations
10.
Yuri, Kazuyo, et al.. (1996). Urinary Tract Infection in Dogs and Cats and Antibiotic Sensitivities of Bacterial Isolates. Journal of the Japan Veterinary Medical Association. 49(7). 449–453. 2 indexed citations
11.
Horiuchi, Motohiro, Kazuyo Yuri, Takehisa SOMA, et al.. (1996). Differentiation of vaccine virus from field isolates of feline panleukopenia virus by polymerase chain reaction and restriction fragment length polymorphism analysis. Veterinary Microbiology. 53(3-4). 283–293. 5 indexed citations
12.
Yamamoto, Shingo, Katsuhisa Nakata, Kazuyo Yuri, et al.. (1996). Assessment of the Significance of Virulence Factors of Uropathogenic Escherichia coli in Experimental Urinary Tract Infection in Mice. Microbiology and Immunology. 40(9). 607–610. 12 indexed citations
13.
Harasawa, Ryô, et al.. (1994). Two genomic variations in the E1 region of canine adenovirus type 2 strains. Veterinary Microbiology. 40(3-4). 373–378. 6 indexed citations
14.
Matsumoto, Shuji, et al.. (1992). AT-4526, A New Quinolone Derivative. American Association of Bovine Practitioners Conference Proceedings. 192–198. 1 indexed citations
15.
Kojima, Kenji K., et al.. (1987). Determination of 22,23-dihydroavermectin B1a in dog plasma using solid-phase extraction and high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 413. 326–331. 21 indexed citations
16.
Katae, Hiromi, et al.. (1987). Prophylactic activity of ivermectin against Dirofilaria immitis infection in dogs: Establishment of effective dose and administration schedule.. The Japanese Journal of Veterinary Science. 49(3). 439–445. 5 indexed citations
17.
Nakamura, Shinichi, Hiromi Katae, Akira Minami, et al.. (1984). IN VITRO AND IN VIVO ANTIBACTERIAL ACTIVITY OF AT-2266. 32(3). 70–85. 2 indexed citations
18.
Nakamura, Shinichi, Katsuhisa Nakata, Hiromi Katae, et al.. (1983). Activity of AT-2266 compared with those of norfloxacin, pipemidic acid, nalidixic acid, and gentamicin against various experimental infections in mice. Antimicrobial Agents and Chemotherapy. 23(5). 742–749. 21 indexed citations
19.
Katae, Hiromi, et al.. (1980). Studies on Chemotherapy of Fish Disease with Erythromycin-I. Fish Pathology. 15(1). 7–16. 12 indexed citations
20.
Shimizu, Masanao, et al.. (1976). Pipemidic Acid: Its Activities Against Various Experimental Infections. Antimicrobial Agents and Chemotherapy. 9(4). 569–574. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.P. Crane Breakdown of academic impact, for papers by JoAnn Dzink-Fox Breakdown of academic impact, for papers by Yoshimi Wakai Breakdown of academic impact, for papers by M. Michéa-Hamzehpour Breakdown of academic impact, for papers by W. TOSCH Breakdown of academic impact, for papers by María Fernández‐Reyes Breakdown of academic impact, for papers by J V Desiderio Breakdown of academic impact, for papers by N. Harnett Breakdown of academic impact, for papers by S J Ryan Arends Breakdown of academic impact, for papers by Kazunori Maebashi
Rankless by CCL
2026